Late perforation by cardiac implantable electronic device leads: clinical presentation, diagnostic clues, and management.

PubWeight™: 1.14‹?› | Rank: Top 10%

🔗 View Article (PMID 20734443)

Published in Clin Cardiol on August 01, 2010

Authors

Marwan M Refaat1, Jana G Hashash, Alaa A Shalaby

Author Affiliations

1: Division of Cardiology, VA Pittsburgh Healthcare System and the University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.

Articles by these authors

Persistent snoring under conscious sedation during colonoscopy is a predictor of obstructive sleep apnea. Gastrointest Endosc (2010) 2.10

Genetic variation in the alternative splicing regulator RBM20 is associated with dilated cardiomyopathy. Heart Rhythm (2011) 1.85

A randomized, controlled, double-blind trial of the adjunct use of tegaserod in whole-dose or split-dose polyethylene glycol electrolyte solution for colonoscopy preparation. Gastrointest Endosc (2008) 1.08

Con: CT colonography-not yet ready for community-wide implementation. Am J Gastroenterol (2010) 1.08

Alcohol consumption is a risk factor for colonic diverticulosis. J Clin Gastroenterol (2013) 0.98

Five-Year Period Prevalence and Characteristics of Anemia in a Large US Inflammatory Bowel Disease Cohort. J Clin Gastroenterol (2016) 0.96

Gastrointestinal bleeding in the setting of anticoagulation and antiplatelet therapy. J Clin Gastroenterol (2009) 0.91

The role of rifaximin in the primary prophylaxis of spontaneous bacterial peritonitis in patients with liver cirrhosis. J Clin Gastroenterol (2012) 0.91

Association of Streptococcus bovis endocarditis and advanced colorectal neoplasia: a case-control study. J Dig Dis (2013) 0.85

Impact of Obesity on the Management and Clinical Course of Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis (2015) 0.84

A randomized trial of standard-dose versus half-dose rabeprazole, clarithromycin, and amoxicillin in the treatment of Helicobacter pylori infection. Eur J Gastroenterol Hepatol (2011) 0.83

Investigational agents for the irritable bowel syndrome. Expert Opin Investig Drugs (2010) 0.83

Demographic and Clinical Predictors of High Healthcare Use in Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis (2016) 0.82

ABO blood group and gastric cancer: rekindling an old fire? South Med J (2007) 0.82

Silent Crohn's Disease: Asymptomatic Patients with Elevated C-reactive Protein Are at Risk for Subsequent Hospitalization. Inflamm Bowel Dis (2015) 0.82

The Influence of Anti-tumor Necrosis Factor Agents on Hemoglobin Levels of Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis (2015) 0.82

A randomized open-label trial of on-demand rabeprazole vs ranitidine for patients with non-erosive reflux disease. World J Gastroenterol (2012) 0.80

The great debate: stopping immunomodulators and biologics in Crohn's disease patients in remission. Expert Rev Gastroenterol Hepatol (2013) 0.79

Duodenal mucosa-associated lymphoid tissue lymphoma successfully treated by radiation therapy. Clin Lymphoma Myeloma (2007) 0.77

Clinical course of Crohn's disease following treatment of lymphoma. Inflamm Bowel Dis (2011) 0.76

Silent Crohn's Disease Predicts Increased Bowel Damage During Multiyear Follow-up: The Consequences of Under-reporting Active Inflammation. Inflamm Bowel Dis (2016) 0.75

An unusual cause of melena. Gastroenterology (2013) 0.75

Multiyear Patterns of Serum Inflammatory Biomarkers and Risk of Colorectal Neoplasia in Patients with Ulcerative Colitis. Inflamm Bowel Dis (2016) 0.75

Rendezvous procedure for the treatment of bile leaks and injury following segmental hepatectomy. Dig Liver Dis (2013) 0.75

An unusual cause of melena and abdominal pain. Gastroenterology (2012) 0.75

Telephone Encounters Predict Future High Financial Expenditures in Inflammatory Bowel Disease Patients: A 3-Year Prospective Observational Study. J Clin Gastroenterol (2017) 0.75

Lasting Impact of Clostridium difficile Infection in Inflammatory Bowel Disease: A Propensity Score Matched Analysis. Inflamm Bowel Dis (2017) 0.75

Ultra-high C-reactive protein levels in hospitalized inflammatory bowel disease (IBD) patients predicts serious complications. Int J Colorectal Dis (2013) 0.75

Prophylaxis with ertapenem in patients with obstructive jaundice undergoing endoscopic retrograde cholangiopancreatography: safety, efficacy, and biliary penetration. South Med J (2011) 0.75